DCTPep ID  DCTPep01303

Peptide Name   Sequence 9 from Patent US 20070293424

Sequence  QGGGGWGQPHGGGWG

Sequence Length  15

UniProt ID  B5SY89  Q5UJG1  Q5UJH8  P40242  Q6EH52  Q5UJG3  P49927  B0FYL5  P52114  P40244  P52113  P23907  Q95M08  P67986  Q5XVM4  O18754  P47852  P79141  O46501  P40256  P61766  P67992  P40257  P04156  P40251   

PubChem CID  Not available

Origin  Homo sapiens

Type  Native peptide

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

PDB ID  Not available

Predicted Structure  DCTPep01303

(Please note that there is the predicted structure, predicted by AlphaFold)

Helicity  Not available

Linear/Cyclic  Not available

Disulfide/Other Bond  Not available

N-terminal Modification  Not available

C-terminal Modification  Not available

Other Modification  None

Chiral  L

Grand average of hydropathicity (GRAVY)  -1.147

Half Life 
  0.8 hours (mammalian reticulocytes, in vitro).
  10 min (yeast, in vivo).
  10 hours (Escherichia coli, in vivo).

Extinction coefficients 
  Ext. coefficient 11000
  Abs 0.1% (=1 g/l) 7.889

Amino acid distribution

Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 2007/0293424 A1

Patent Title  Antitumoral and Antiviral Peptides.

Other Iinformation  Granted Patent Family: 10s / 10ex; Family Jurisdictions: EP, RU, AU, ZA, US, WO; Legal Status: Active; Application No: 58571504 ; Filed:Dec 30, 2004; Published: Dec 20, 2007; Earliest Priority: Jan 15, 2004; Granted: Feb 12, 2013

Other Published ID  EP1705182A1  EP1705182A4  EP1705182B1  US8372406  WO2005068491A1